DATA MODUL AG O.N./ DE0005498901 /
2024-05-30 12:45:07 PM | Chg. +0.400 | Volume | Bid2024-05-30 | Ask2024-05-30 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
32.600EUR | +1.24% | - Turnover: - |
32.600Bid Size: 307 | 33.200Ask Size: 301 | 114.95 mill.EUR | - | 14.55 |
GlobeNewswire
1:00 PM
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment ...
GlobeNewswire
1:00 PM
Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Withi...
GlobeNewswire
1:00 PM
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conf...
GlobeNewswire
1:00 PM
Beamr Cloud upgrade for enterprises: customizable video service with enhanced security and privacy
GlobeNewswire
1:00 PM
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
GlobeNewswire
1:00 PM
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
GlobeNewswire
1:00 PM
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis ...
GlobeNewswire
1:00 PM
17 Education & Technology Group Inc. to Report First Quarter 2024 Unaudited Financial Results on Jun...
GlobeNewswire
1:00 PM
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and P...
GlobeNewswire
1:00 PM
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Trea...
GlobeNewswire
1:00 PM
Rivalry Reports First Quarter 2024 Results, Expands Into Crypto Segment Through Rivalry Token
GlobeNewswire
1:00 PM
Virtu Financial, Inc. Announces Investor Meetings for Potential Opportunistic Offering of Senior Sec...